Pituitary & hypothalamus

An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic Syndrome of Inappropriate Antidiuresis (SIAD)

J Clin Endocrinol MetabPublished Secondary analysis of the SANDx randomised trial

Authors' conclusion

An increase in plasma sodium levels in outpatients with chronic hyponatremia due to SIAD, even when mild, was associated with an increase in bone formation index (P1NP/CTX) triggered by an increase in P1NP, a surrogate marker of osteoblast function.

Study context

Population
Outpatients with chronic SIAD; 6 women, median age 73 yearscrossover
Participants
11 outpatients
Comparison
Change in plasma sodium vs change in bone turnover markers
Primary endpoint
Relationship between change in bone formation index (BFI, P1NP/CTX) and change in plasma sodium
Methodological detailspredefined secondary analysis, double-blind, crossover, placebo-controlled, December 2017 to August 2021
  • Predefined secondary analysis
  • Double-blind
  • Crossover
  • Placebo-controlled
  • December 2017 to August 2021

Primary result

As reported in the abstract

Association of sodium change with bone markers

Correlation of sodium change with bone formation index (BFI) change: ρ (P < .001)

.55

Correlation of sodium change with P1NP change: ρ (P = .004)

.45

Increase in BFI per 1 mmol/l sodium increase

5.21

95% CI 1.41–9.00P = .013

Increase in P1NP per 1 mmol/l sodium increase, µg/l

1.48

95% CI .26–2.62P = .03

Original publication

An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD. J Clin Endocrinol Metab. Published 25 April 2023. doi:10.1210/clinem/dgad238

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.